RESUMO
Characterization of local inflammation at culprit superficial femoral artery (SFA) stenosis has not been studied. We hypothesized that arterial cytokine concentrations would be greater at sites of stenosis. Twenty patients with ≥50 % angiographic stenosis of the SFA had blood drawn just proximal to the lesion and from a contralateral site free of disease. A microplate immunoassay was used to determine the concentrations of 42 distinct cytokines and growth factors. Exact conditional logistic analysis was used to compare measures at the two sites with interaction terms describing clinical factors used to identify difference mediators. Interaction terms identified clinical factors that could predict cytokine levels. The concentrations of soluble CD40 ligand (sCD40L; mean 212 and 177 pg/ml, p = 0.01) and tumor necrosis factor beta (TNF-B; mean 16.6 and 15.9 pg/ml, p = 0.04) were increased immediately proximal to areas of stenosis. Factors associated with greater concentrations at sites of stenosis were bilateral ankle-brachial index ≤0.90 (p = 0.04), no statin use (p = 0.02), claudication (p = 0.03), low leukocyte count (p = 0.03), absence of limb ischemia (p = 0.04) and lack of aspirin or clopidogrel therapy (p ≤ 0.06). Greater concentrations of sCD40L and TNF-B at sites of stenosis suggest that these cytokines play a role in the pathogenesis of symptomatic SFA disease. Our results also suggest that statin, aspirin and clopidogrel therapy may attenuate localized inflammation in the SFA, though due to a small sample size and the use of multiple comparisons across groups, these findings can be viewed as hypothesis generating only. In conclusion, selected cytokines are heightened at culprit SFA lesions and inflammation may be modulated by statin and antiplatelet therapy.
Assuntos
Ligante de CD40/sangue , Artéria Femoral , Linfotoxina-alfa/sangue , Placa Aterosclerótica/sangue , Aspirina/administração & dosagem , Clopidogrel , Constrição Patológica/sangue , Constrição Patológica/tratamento farmacológico , Feminino , Humanos , Inibidores de Hidroximetilglutaril-CoA Redutases/administração & dosagem , Isquemia/sangue , Isquemia/tratamento farmacológico , Extremidade Inferior/irrigação sanguínea , Masculino , Pessoa de Meia-Idade , Placa Aterosclerótica/tratamento farmacológico , Inibidores da Agregação Plaquetária/administração & dosagem , Estudos Prospectivos , Ticlopidina/administração & dosagem , Ticlopidina/análogos & derivadosRESUMO
Campeau in 1989 and subsequently Kiemeneij and Laarman in 1993 successfully attempted diagnostic cardiac catheterization and percutaneous coronary intervention (PCI), respectively, using the radial artery. Since then, the technique has evolved significantly with improvement in catheters and operators gaining experience in transradial (TR) procedures. Short recovery time, less bleeding complications, and enhanced patient satisfaction made the TR approach a preferred route to perform cardiac catheterization and PCIs in an increasing number of countries. As operators become more comfortable with this approach, they are using it to perform increasingly complex procedures such as rotational atherectomy and opening chronic total occlusions. Despite its increasing acceptance due to the advantages it offers, TR access was used only in about 1.32% of patients who underwent PCI in the US in a report by Rao et al. In this review, we summarize the advantages and disadvantages of the TR approach trying to identify the possible causes of it not being adopted in US.